
COPD: Review of Current Treatment Guidelines


Chronic obstructive pulmonary disease is considered a long-term airway disease characterized by persistent respiratory symptoms and airflow limitations usually caused by exposure to noxious particles or gases. COPD continues to be a major cause of chronic morbidity and mortality throughout the world despite being a treatable and preventable disease. This CME activity discusses the pharmacological management and approach to COPD including the various assessment tools, and treatment options/regimens, and provides an overview of the latest evidence-based guidelines in decision-making regarding pharmacotherapeutic management.
Educational Objectives:
After completing this activity, the participant should be better able to:
1. Examine pharmacological assessment tools used in the diagnosis and staging of COPD.
2. Cite the various pharmacotherapeutic options for the treatment of COPD.
3. Design a therapy regimen for patients with symptoms or exacerbations after initial treatment for COPD.
4. Apply evidence-based guidelines in decision-making regarding the pharmacotherapeutic management of COPD.
The estimated time to complete this activity is 1 hour.
This activity is jointly provided by Your CE Source and eMedEd.